Suppr超能文献

米索前列醇用于终止妊娠的自我给药:安全性与有效性

Self-administration of misoprostol for termination of pregnancy: safety and efficacy.

作者信息

Kiran U, Amin P, Penketh R J

机构信息

Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK.

出版信息

J Obstet Gynaecol. 2004 Feb;24(2):155-6. doi: 10.1080/01443610410001645451.

Abstract

We conducted a retrospective study to determine the efficacy and safety of self-administration of vaginal misoprostol (following oral mifeprestone) for medical termination of pregnancy. This study revealed that self-administration was accepted by the majority of the patients (90%) and the success rate (98.4%) and duration of hospital stay was not altered significantly compared to our previous year's data, where women were administered vaginal misoprostol by the staff. Based on this study's results, we are of the opinion that this regimen not only demedicalises the problem but also decreases the workload for the medical staff.

摘要

我们进行了一项回顾性研究,以确定口服米非司酮后自行阴道给药米索前列醇用于药物终止妊娠的有效性和安全性。该研究表明,大多数患者(90%)接受自行给药,与我们前一年的数据相比,成功率(98.4%)和住院时间没有显著变化,前一年是由工作人员为女性阴道给药米索前列醇。基于这项研究的结果,我们认为这种给药方案不仅使问题非医疗化,还减轻了医务人员的工作量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验